4
Changes in Ownership
UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000185
Chairperson & CEO sold 1,614 shares at an average $584.59 ($943,521)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
ROTHBLATT MARTINE A · Chairperson & CEO
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-11-09 | Sale : show line 1 in the form 10b5-1 | −494 | $583.80 | $288,398 | 325,563 | I |
| 2026-11-09 | Sale : show line 2 in the form 10b5-1 | −840 | $584.70 | $491,148 | 324,723 | I |
| 2026-11-09 | Sale : show line 3 in the form 10b5-1 | −280 | $585.63 | $163,975 | 324,443 | I |
| Open-market sales · 1,614 sh · avg $584.59 · $943,521 | ||||||
Loading xslF345X06/primarydocument.xml…